Medical Condition News

RSS

Louisville Chief of Cardiovascular Medicine earns APS' Walter B. Cannon Award

Heart failure affects roughly six million Americans, yet treatment consists of either a heart transplant or the insertion of mechanical devices that assist the heart. This is unacceptable to Roberto Bolli, MD, Chief of the Division of Cardiovascular Medicine at the University of Louisville in Louisville, Ky., which is why he is on a mission to make cardiac stem cell treatment an option for all who must cope with the limitations of a failing heart.

11 Apr 2011

NCI, ASH, AMEH join to improve care for patients with AML

A workshop being held today will serve as the launch of a unique project that unites the American Society of Hematology, the Agrupaci-n Mexicana para el Estudio de la Hematolog-a, and the National Cancer Institute in pursuit of a common goal: improving the care of patients with acute myeloid leukemia.

11 Apr 2011

Blueberry polyphenols can reduce obesity

The benefits of blueberry consumption have been demonstrated in several nutrition studies, more specifically the cardio-protective benefits derived from their high polyphenol content.

11 Apr 2011

Increased levels of plasma renin activity protein may predict major cardiovascular event in high-risk patients

Increased levels of a protein that helps regulate the body's blood pressure may also predict a major cardiovascular event in high-risk patients, according to a study led by St. Michael's Hospital's cardiovascular surgeon Subodh Verma. Measuring the amount of the protein, known as plasma renin activity (PRA), in the blood stream may give doctors another tool to assess a patient's risk and help prevent a heart attack or stroke.

8 Apr 2011

Revised definition of catastrophic impairment may result in reduction of benefits

The Alliance of Community Medical Rehabilitation Providers is urging the government to protect seriously injured car accident victims when it considers the report of the Catastrophic Impairment Expert Panel. The report is scheduled to be released next week.

8 Apr 2011

Key regulator of fat cell development may provide a target for obesity and diabetes drugs

New research by scientists at The Scripps Research Institute and collaborating institutions has identified a key regulator of fat cell development that may provide a target for obesity and diabetes drugs.

8 Apr 2011

Elekta to highlight Leksell Gamma Knife Perfexion radiosurgery solution at AANS 2011

At the 2011 American Association of Neurological Surgeons (AANS) Annual Meeting, April 9-13 at the Colorado Convention Center, Elekta (booth #1717) will highlight characteristics of Leksell Gamma Knife® Perfexion™ that separate the system from other radiosurgery solutions.

From Elekta 8 Apr 2011

Polaris' ADI-PEG 20 exhibits potential against AML, GBM and bladder cancer

Polaris Group announced today that data from preclinical studies suggest ADI-PEG 20, the Company's pegylated arginine deiminase therapeutic, may be effective in treating acute myeloid leukemia (AML), glioblastoma multiforme (GBM) and bladder cancer.

8 Apr 2011

FDA grants tentative approval for Hi-Tech Pharmacal's generic Combigan ANDA

Hi-Tech Pharmacal Co., Inc., a specialty pharmaceuticals company, announced today that the US Food and Drug Administration, (FDA) granted tentative approval for the Company's Abbreviated New Drug Application, (ANDA) for brimonidine tartrate with timolol maleate ophthalmic solution, the generic for Allergan's Combigan® ophthalmic solution which had sales of $108 million for the 12 months ended December 2010 according to IMS sales data.

8 Apr 2011

Watson confirms patent challenge by Alcon for generic Vigamox

Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Moxifloxacin Hydrochloride Ophthalmic Solution USP, 0.5%. Watson's Moxifloxacin Hydrochloride Ophthalmic Solution USP, 0.5% is a generic version of Alcon, Inc.'s Vigamox®, an antibiotic solution that is indicated for the treatment of bacterial conjunctivitis.

8 Apr 2011

FDA accepts Antares Pharma's Anturol NDA for filing, assigns PDUFA date

Antares Pharma, Inc. today announced the New Drug Application (NDA) for Anturol® Gel in patients with overactive bladder (OAB) was accepted for filing for review by the U.S. Food and Drug Administration (FDA). Anturol is an oxybutynin gel incorporating Antares' ATD Gel technology.

8 Apr 2011

Vascular Disease Foundation invites applicants for ambassador program

If you or someone you love have been affected by vascular disease and have a willingness to help others, the Vascular Disease Foundation (VDF) is calling for applications to join its ambassador program to help promote vascular disease awareness.

8 Apr 2011

Researchers identify new gene that predisposes people to both autism, epilepsy

Researchers from the CHUM Research Centre have identified a new gene that predisposes people to both autism and epilepsy.

8 Apr 2011

New report finds 13,000 cancer cases per year in the UK due to alcohol consumption

Alcohol causes at least 13,000 cases of cancer a year in the UK, according to a new report published in the British Medical Journal today.

8 Apr 2011

Adult survivors of childhood CNS tumors have persistent, unmet health care needs

Patients treated in childhood for tumours of the central nervous system have persistent and unmet health care needs even in adulthood, according to a comprehensive study from Karolinska Institutet which investigated an entire cohort of patients in Sweden.

8 Apr 2011

Biochemical battle of the bulge: New developments

Dozens of researchers in the coming days will lay out what's around the corner in the biochemical battle of the bulge as part of the Experimental Biology 2011 conference in Washington, D.C.

8 Apr 2011

Computational modeling provides more knowledge of lipoprotein properties

Computational modeling increases our knowledge of lipoprotein properties that cannot be measured using experimental methods. Lipoproteins are particles that transport cholesterol in our bloodstream. According to the doctoral dissertation of Master of Science in Technology Linda Kumpula (Aalto University School of Science), the differences in the composition, size and number of lipoprotein particles transporting cholesterol in individuals can be computationally modeled using experimental data.

8 Apr 2011

New publication on therapeutic hypothermia and temperature management

The successful use and evaluation of therapeutic hypothermia to improve survival and reduce the risk of neurological consequences following an out-of-hospital heart attack are explored in the premier issue of Therapeutic Hypothermia and Temperature Management, a new quarterly peer-reviewed journal published by Mary Ann Liebert, Inc.

8 Apr 2011

Study: Majority of hospital deaths are due to late cancer diagnosis

Late cancer diagnosis in Northern Ireland contributes to hospital deaths despite patient's preference to die at home according to a major report launched at Queen's University Belfast.

8 Apr 2011

Loyola's HARRT program enhances emergency angioplasty times

The availability of an in-house, around-the-clock interventional cardiology team dramatically decreases the time it takes to restore blood flow to heart attack patients, according to data presented this week.

8 Apr 2011

Medical Condition News

Louisville Chief of Cardiovascular Medicine earns APS' Walter B. Cannon Award

NCI, ASH, AMEH join to improve care for patients with AML

Blueberry polyphenols can reduce obesity

Increased levels of plasma renin activity protein may predict major cardiovascular event in high-risk patients

Revised definition of catastrophic impairment may result in reduction of benefits

Key regulator of fat cell development may provide a target for obesity and diabetes drugs

Elekta to highlight Leksell Gamma Knife Perfexion radiosurgery solution at AANS 2011

Polaris' ADI-PEG 20 exhibits potential against AML, GBM and bladder cancer

FDA grants tentative approval for Hi-Tech Pharmacal's generic Combigan ANDA

Watson confirms patent challenge by Alcon for generic Vigamox

FDA accepts Antares Pharma's Anturol NDA for filing, assigns PDUFA date

Vascular Disease Foundation invites applicants for ambassador program

Researchers identify new gene that predisposes people to both autism, epilepsy

New report finds 13,000 cancer cases per year in the UK due to alcohol consumption

Adult survivors of childhood CNS tumors have persistent, unmet health care needs

Biochemical battle of the bulge: New developments

Computational modeling provides more knowledge of lipoprotein properties

New publication on therapeutic hypothermia and temperature management

Study: Majority of hospital deaths are due to late cancer diagnosis

Loyola's HARRT program enhances emergency angioplasty times

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Latest News